Dr. Niamh Lynam-Lennon
Research Assistant Professor, Surgery
- Research Institute:
Trinity Translational Medicine Institute (TTMI)
- Contact e-mail:
- Research Area(s):
Gastrointestinal Cancer, Radioresistance, Predictive Biomarkers, Energy Metabolism, microRNA, Complement System.
Research Description:
Dr Niamh Lynam-Lennon is a Research Assistant Professor and Principle Investigator in the Dept. of Surgery where she works in the area of treatment resistance (Radiation and Chemotherapy) in gastrointestinal cancer. She directs a translational oncology research team focused on two main areas; prediction of response to therapy and identification of novel treatment strategies to enhance the tumour response to therapy, with the ultimate goal of improving treatment and survival for patients.
Her research spans several topical areas including miRNA and gene expression profiling, altered mitochondrial function and energy metabolism and altered inflammation (specifically the complement system) in treatment resistance of gastrointestinal cancers utilising both novel cell line models of treatment resistance and blood and tumour samples from patients. She is internationally recognised for her work in translational oncology, with >30 publications, and has been awarded > €1.7 million in internationally peer-reviewed funding.
Dr Lynam-Lennon actively drives design and delivery of Translational Oncology education, acting as a module co-ordinator on the MSc in Translational Oncology at TCD and lectures to students on two MSc programs at TCD in several areas of cancer biology and treatment resistance. She currently supervises 2 PhD students and has supervised 2 graduated PhD students and 12 undergraduate and postgraduate students from both TCD and UCD on laboratory-based projects.
She is elected Treasurer of the Irish Association for Cancer Research and The Irish Radiation Research Society and sits on the Environmental Protection Agency (EPA) Advisory Committee.
